HomeNDC LookupRxCUI directory › RxCUI 105292

Isoniazid 10 MG/ML Oral Solution — RxCUI 105292

RxNorm drug concept · Semantic clinical drug
RxCUI 105292 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI105292
Official nameIsoniazid 10 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asINH 10 MG/ML Oral Solution; isoniazid 50 MG in 5 mL Oral Solution; isoniazid 50 MG per 5 ML Oral Solution; isoniazid 50 MG per 5 ML Syrup
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)623 prescriptions · 5 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Isoniazid: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • TB bacteria are clever — they can develop resistance to a single drug very quickly, which would make your infection much harder to treat. Using isoniazid together with other anti-T...
  • Why do I have to take isoniazid with other TB medications? Can't I just take this one?
  • Liver damage is the most serious risk with isoniazid, and it's important to take it seriously — but your doctor will be monitoring you for this. You'll have monthly check-ins, and...
  • I heard isoniazid can hurt my liver. How worried should I be?
📖 Read our full Isoniazid guide →

🕸️ Concept Web — How Isoniazid 10 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Isoniazid 10 MG/ML Oral Solution RxCUI 105292

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Isoniazid 6038
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Isoniazid Oral Solution 379262
    • Isoniazid Oral Liquid Product 1161934
    • Isoniazid Oral Product 1161935
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Isoniazid 10 MG/ML 317390

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Isoniazid 10 MG/ML SCDC · 317390
  • Isoniazid Oral Solution SCDF · 379262
  • Isoniazid Oral Liquid Product SCDG · 1161934
  • Isoniazid Oral Product SCDG · 1161935

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 105292 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
46287-0009-01 473 mL in 1 BOTTLE (46287-009-01) Isoniazid CMP Pharma, Inc. 1983-11-11
62135-0550-47 473 mL in 1 BOTTLE (62135-550-47) Isoniazid Chartwell RX, LLC 2023-05-10
Observed labelers: Chartwell RX, LLC (1) · CMP Pharma, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.